Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel + Cisplatin Neo-Adjuvant in UCNT
NCT00916097Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jul 2002
- Primary completion
- Nov 2005
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of docetaxel in undifferentiated nasopharyngeal carcinoma (NPC), sponsored by Sanofi. Started Jul 2002; status: completed.
02
Drugs
docetaxel
03
Conditions
undifferentiated nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT00916097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00916097.